Last Updated: June 29, 2026

MEPERIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Meperidine patents expire, and what generic alternatives are available?

Meperidine is a drug marketed by Wyeth Ayerst, Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Hikma, Barr, Duramed Pharms Barr, Epic Pharma Llc, Genus, Specgx Llc, Strides Pharma Intl, Sun Pharm Inds Inc, Sun Pharm Industries, Hospira, and Icu Medical Inc. and is included in forty-three NDAs.

The generic ingredient in MEPERIDINE is meperidine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for MEPERIDINE?
  • What are the global sales for MEPERIDINE?
  • What is Average Wholesale Price for MEPERIDINE?
Summary for MEPERIDINE
US Patents:0
Applicants:19
NDAs:43
Drug Prices: Drug price information for MEPERIDINE
DailyMed Link:MEPERIDINE at DailyMed
Drug patent expirations by year for MEPERIDINE
Drug Prices for MEPERIDINE

See drug prices for MEPERIDINE

US Patents and Regulatory Information for MEPERIDINE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040331-002 May 28, 1999 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
West-ward Pharms Int MEPERIDINE HYDROCHLORIDE meperidine hydrochloride INJECTABLE;INJECTION 080455-009 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Specgx Llc MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040352-002 Jun 13, 2000 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Icu Medical Inc MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE meperidine hydrochloride INJECTABLE;INJECTION 088432-001 Aug 16, 1984 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Genus MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040893-004 Jun 24, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Strides Pharma Intl MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040191-001 Dec 17, 1998 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Industries MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 080448-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links